title: Induction of labor: a comparative study of intravaginal misoprostol and dinoprostone.
abstract: OBJECTIVE
  To compare the efficacy and safety of intravaginal misoprostol and dinoprostone for elective induction of labor in nulliparous women with an unfavorable cervix.
  
  
  METHODS
  A quasi-experimental study was conducted in Bahawal Victoria Hospital, Bahawalpur, Pakistan, from July 1, 2005 to August 31, 2006. A total of 120 primigravid women with gestational ages of > 40 weeks to < 42 weeks were divided into two groups. Group A (n = 60) was given 50 microg of misoprostol and Group B (n = 60) was given 3 mg of dinoprostone every 6 hours, for a maximum of three doses.
  
  
  RESULTS
  The induction to onset of significant uterine contractions and delivery intervals were lower in Group A than in Group B (6.1 vs. 7.2 hours; p = 0.16; and 8.2 vs. 11.0 hours; p = 0.007, respectively). Group A had a lower cesarean section rate than Group B (7% vs. 30%; p = 0.003), but a higher rate of uterine hyperstimulation (10% vs. 3%; p = 0.16), tachysystole (17% vs. 3%; p = 0.02), and neonatal admissions to the intensive care unit within 24 hours of delivery (4 vs. 3; p = 0.71) and after 24 hours (2 vs. 1; p = 0.56) than Group B.
  
  
  CONCLUSIONS
  Vaginal misoprostol is more effective than dinoprostone for the elective induction of labor beyond 40 weeks of gestation, but is associated with more uterine hyperstimulation, tachysystole, and neonatal intensive care unit admissions.
authors: Department of Obstetrics and Gynecology, Hera General Hospital, Makkah, Saudi Arabia.
authors: Aqueela
authors: A
authors: Ayaz
authors: Saima
authors: S
authors: Shaukat
authors: Mian Usman
authors: MU
authors: Farooq
authors: Khalid
authors: K
authors: Mehmood
authors: Iftikhar
authors: I
authors: Ahmad
authors: Muhammad Luqman
authors: ML
authors: Ali Bahoo
mesh_terms: D000282:Administration, Intravaginal; D000328:Adult; D002585:Cesarean Section / Q000706:statistics & numerical data; D015232:Dinoprostone / Q000627:therapeutic use*; D005260:Female; D006801:Humans; D007231:Infant, Newborn; D007363:Intensive Care Units, Neonatal; D007751:Labor, Induced / Q000379:methods*; D016595:Misoprostol / Q000627:therapeutic use*; D010120:Oxytocics / Q000627:therapeutic use*; D010343:Patient Admission / Q000706:statistics & numerical data; D011247:Pregnancy; D014590:Uterine Contraction / Q000187:drug effects
chemical_list: D010120:Oxytocics; D016595:Misoprostol; D015232:Dinoprostone